top of page

Patient Receiving Ocrelizumab may be associated with PML

Roche is investigating one case of progressive multifocal leukoencephalopathy (PML) in a patient with multiple sclerosis (MS) after treatment with ocrelizumab (Ocrevus).

The Roche said that according to the treating physician, the case is a “carryover” from treatment with natalizumab (Tysabri, Biogen), which is known to be associated with PML. It reports that the patient, who was JC virus (JCV) positive, had been treated with natalizumab for 3 years, with the last infusion in February 2017.


Recent Posts

See All

In India, First Three Zika Virus Cases confirmed by WHO

On 15 May 2017, the Ministry of Health and Family Welfare-Government of India (MoHFW) reported three laboratory-confirmed cases of Zika virus disease in Bapunagar area, Ahmedabad District, Gujarat, St


5 स्टार में से 0 रेटिंग दी गई।
अभी तक कोई रेटिंग नहीं

रेटिंग जोड़ें
bottom of page